140 related articles for article (PubMed ID: 2841264)
41. Protection of cultured mammalian cells by S-2-(3-aminopropylamino)ethylphosphorothioic acid(WR-2721).
Antoku S
Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1481-5. PubMed ID: 6313559
[TBL] [Abstract][Full Text] [Related]
42. Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injection.
Spence AM; Krohn KA; Edmondson SW; Steele JE; Rasey JS
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1479-82. PubMed ID: 3019963
[TBL] [Abstract][Full Text] [Related]
43. The time course of radioprotection by WR 2721 in mouse skin.
Travis EL; De Luca AM; Fowler JF; Padikal TN
Int J Radiat Oncol Biol Phys; 1982 May; 8(5):843-50. PubMed ID: 6286557
[TBL] [Abstract][Full Text] [Related]
44. Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721.
Milas L; Hunter N; Ito H; Peters LJ
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):41-8. PubMed ID: 6321411
[TBL] [Abstract][Full Text] [Related]
45. Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents.
Hanson WR
Radiat Res; 1987 Aug; 111(2):361-73. PubMed ID: 2819937
[TBL] [Abstract][Full Text] [Related]
46. Topical or systemic 16, 16 dm prostaglandin E2 or WR-2721 (WR-1065) protects mice from alopecia after fractionated irradiation.
Geng L; Hanson WR; Malkinson FD
Int J Radiat Biol; 1992 Apr; 61(4):533-7. PubMed ID: 1349335
[TBL] [Abstract][Full Text] [Related]
47. Radiation-induced lymphoid tumors and radiation lethality are inhibited by combined treatment with small doses of zinc aspartate and WR 2721.
Floersheim GL; Christ A; Koenig R; Racine C; Gudat F
Int J Cancer; 1992 Oct; 52(4):604-8. PubMed ID: 1328072
[TBL] [Abstract][Full Text] [Related]
48. Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure.
Cassatt DR; Fazenbaker CA; Bachy CM; Kifle G; McCarthy MP
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):901-7. PubMed ID: 15708273
[TBL] [Abstract][Full Text] [Related]
49. Modification of radiosensitivity of bone marrow lymphocytes by WR-2721.
Naruka K; Bhartiya HC
Acta Oncol; 1987; 26(4):317-8. PubMed ID: 2825734
[No Abstract] [Full Text] [Related]
50. Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumors.
Clement JJ; Johnson RK
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):539-42. PubMed ID: 6286550
[TBL] [Abstract][Full Text] [Related]
51. Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation.
Molkentine JM; Fujimoto TN; Horvath TD; Grossberg AJ; Garcia CJG; Deorukhkar A; de la Cruz Bonilla M; Lin D; Samuel ELG; Chan WK; Lorenzi PL; Piwnica-Worms H; Dantzer R; Tour JM; Mason KA; Taniguchi CM
Sci Rep; 2019 Feb; 9(1):1949. PubMed ID: 30760738
[TBL] [Abstract][Full Text] [Related]
52. Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage.
Liu W; Chen Q; Wu S; Xia X; Wu A; Cui F; Gu YP; Zhang X; Cao J
J Radiat Res; 2015 Mar; 56(2):278-86. PubMed ID: 25617317
[TBL] [Abstract][Full Text] [Related]
53. Radioprotection of mouse skin vasculature and the RIF-1 fibrosarcoma by WR-2721.
Penhaligon M
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1541-4. PubMed ID: 6090358
[TBL] [Abstract][Full Text] [Related]
54. Radioprotection against cataract formation by WR-77913 in gamma-irradiated rats.
Menard TW; Osgood TB; Clark JI; Spence AM; Steele JE; Krohn KA; Livesey JC
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1483-6. PubMed ID: 3019964
[TBL] [Abstract][Full Text] [Related]
55. WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment.
Phan TP; Crane CH; Janjan NA; Vrdoljak E; Milas L; Mason KA
Int J Pancreatol; 2001; 29(1):19-23. PubMed ID: 11558629
[TBL] [Abstract][Full Text] [Related]
56. Induction of micronucleated erythrocytes by MEA, AET, WR-2721 and X-rays.
Mazur L
Mutat Res; 1995 Jun; 334(3):317-22. PubMed ID: 7753095
[TBL] [Abstract][Full Text] [Related]
57. Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
Twentyman PR
Br J Cancer; 1983 Jan; 47(1):57-63. PubMed ID: 6295428
[TBL] [Abstract][Full Text] [Related]
58. Radioprotection of mouse colony forming units-spleen against heavy-charged particle damage by WR 2721.
Afzal SM; Ainsworth EJ
Radiat Res; 1987 Jan; 109(1):118-26. PubMed ID: 3027738
[TBL] [Abstract][Full Text] [Related]
59. Radiation-induced craniofacial bone growth inhibition: efficacy of cytoprotection following a fractionated dose regimen.
La Scala GC; O'Donovan DA; Yeung I; Darko J; Addison PD; Neligan PC; Pang CY; Forrest CR
Plast Reconstr Surg; 2005 Jun; 115(7):1973-85. PubMed ID: 15923846
[TBL] [Abstract][Full Text] [Related]
60. Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hemopoietic reconstitution and increase survival.
Patchen ML; MacVittie TJ; Souza LM
Int J Radiat Oncol Biol Phys; 1992; 22(4):773-9. PubMed ID: 1371988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
